EU MDR imposes ongoing post-market surveillance obligations on every manufacturer. This is not a one-time task — it is a permanent, structured process that must be maintained throughout the lifetime of your device on the EU market.
Articles 83 to 86 of EU MDR establish mandatory post-market surveillance requirements for all manufacturers. The system must be proactive, systematic and based on a documented plan — not reactive to complaints alone.
Every manufacturer must establish and document a post-market surveillance plan before placing a device on the market. The plan must specify the methods and processes used to collect and analyse real-world data on device performance, safety and clinical outcomes.
The Periodic Safety Update Report summarises all post-market surveillance data collected and assesses whether the benefit-risk profile of the device remains acceptable. Required for Class IIa, IIb and III devices.
Class I manufacturers prepare a Post-Market Surveillance Report instead of a PSUR. Less formal than a PSUR but must still document the conclusions drawn from PMS data and justify any actions taken.
Post-Market Clinical Follow-up is required where pre-market clinical data is insufficient or where new information may affect the clinical evaluation. A PMCF plan and evaluation report must be documented and regularly updated.
We review your existing post-market documentation and identify what is missing or non-compliant against EU MDR Articles 83–86 and Annex XIV requirements.
We write a complete, device-specific PMS plan covering data sources, collection intervals, analysis methodology, signal detection thresholds and escalation procedures.
We prepare your PSUR or PMS Report based on available post-market data, literature review and complaint analysis — ready for submission to your Notified Body.
Where required, we design a PMCF plan with appropriate study design, define evaluation criteria and prepare the PMCF evaluation report.
We can manage your PMS system on an ongoing annual basis — ensuring PSUR updates, literature surveillance and PMCF evaluations are completed on schedule.
Book a free 20-minute call. Clear assessment of what you need and what it will cost — no obligation.
Book Free 20-Min Call →Visit our EU MDR consultant Sweden homepage or browse our EU MDR FAQ.